aid: abpro
name: Abpro
description: 'Abpro Holdings, Inc. is a clinical-stage biotechnology company headquartered
  in the Boston area (Woburn / Burlington, Massachusetts) that develops next-generation
  multispecific antibody therapeutics for oncology and ophthalmology. Its DiversImmune
  antibody-discovery platform and MultiMab multispecific-engineering platform are used
  to build bispecific and tetravalent T-cell-engager constructs, led by ABP-102/CT-P72,
  a tetravalent bispecific HER2 x CD3 T-cell engager partnered with Celltrion, alongside
  the ABP-110, ABP-150 and ABP-201 programs. Abpro is a drug developer rather than a
  software company: its public web surface is a corporate and investor-relations site,
  and it publishes no developer program, public API, SDK, webhook surface, or machine-readable
  specification of any kind.'
image: https://abpro.co/wp-content/uploads/2023/05/Abpro_logo_with_trademark-transparent.png
url: https://raw.githubusercontent.com/api-evangelist/abpro/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Antibody Therapeutics
- Oncology
- Life Sciences
- Drug Discovery
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abpro-domain-security.yml
- type: Website
  url: https://abpro.co/
- type: About
  url: https://abpro.co/about-us/
- type: Technology
  url: https://abpro.co/technology/
- type: Pipeline
  url: https://abpro.co/pipeline/
- type: News
  url: https://abpro.co/news/
- type: Careers
  url: https://abpro.co/careers/
- type: Contact
  url: https://abpro.co/contact/
- type: InvestorRelations
  url: https://investor.abpro.co/
- type: PrivacyPolicy
  url: https://abpro.co/privacy-policy/
- type: SecondaryMarket
  url: https://forgeglobal.com/abpro_stock/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Abpro is a clinical-stage antibody-therapeutics developer whose product is a drug
    pipeline rather than software, and its entire published surface is the 33-page
    corporate WordPress site listed in sitemap_index.xml — every developer path
    (/developers, /docs, /api, /graphql, /openapi.json) 404s and there is no
    github.com/abpro organization.
  evidence:
  - url: https://abpro.co/openapi.json
    status: 404
  - url: https://abpro.co/graphql
    status: 404
  - url: https://abpro.co/developers
    status: 404
  - url: https://abpro.co/.well-known/agent-card.json
    status: 404
  - url: https://abpro.co/.well-known/agent.json
    status: 404
  - url: https://abpro.co/llms.txt
    status: 404
  - url: https://api.github.com/orgs/abpro
    status: 404
  - url: https://investor.abpro.co/
    status: 403
  - url: https://abpro.co/sitemap_index.xml
    status: 200
  checked: '2026-08-06'